TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. ATB Capital reduced their price target on Aurora Cannabis from C$11.00 to C$8.50 ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

(1) Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A.

Aurora Cannabis Inc ... of more than 2 to 1. Curaleaf Holdings, Inc. (CURLF), another stock in the same industry, has yet to report results for the quarter ended December 2024.

Aurora Cannabis ... above 1.2600 in the European session on Tuesday. The data from the UK showed that the ILO Unemployment Change remained unchanged at 4.4% in the three months to December ...

Dario Sabaghi covers the cannabis industry with a focus on Europe. Canadian company Aurora Cannabis has announced ... and less than 1 % CBD, which is expected to be available on January 27.

Industry insiders and researchers say the industry is riddled with loopholes that allow consumers to be deceived about everything from the marijuana’s potency, to the prevalence of dangerous ...

Aurora Cannabis (TSX:ACB) released its financial and operational results for Q3 fiscal 2025, showcasing significant growth ...